文献速递认知障碍与痴呆神经免疫

多发性硬化中核间性眼肌麻痹的诊断与量化

Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia.
PubMed 文献 · Neurology · 2019-04-19

本研究采用标准化红外眼动记录协议(DEMoNS)量化多发性硬化(MS)患者与健康对照者的水平扫视,通过计算扫视分离指数(VDI)等参数诊断核间性眼肌麻痹(INO)。INO组报告复视症状的比例(35.2%)高于非INO组(18.4%,p=0.010),且视觉相关生活质量更低(中位数89.9 vs 91.8,p=0.011)。

要点

  • 红外眼动记录可客观量化MS患者的INO,15°水平扫视VDI AUC诊断准确性最高。
  • 基于VDI AUC与峰速度/幅度比联合检测,MS中INO患病率为34%。
  • 合并INO的MS患者复视主诉更多且视觉相关生活质量更低。

核心结论

  • 本研究提供了MS中INO的准确、定量且具有临床相关性的定义。

主要发现

  • 15°水平扫视的VDI AUC诊断准确性最高。
  • 基于VDI AUC与峰速度/幅度比联合检测,MS中INO患病率为34%。
  • INO组35.2%报告复视,非INO组18.4%(p=0.010)。
  • INO组视觉相关生活质量中位数89.9(四分位距12.8),非INO组91.8(四分位距9.3,p=0.011)。

关键数值与推荐

  • VDI计算为外展眼与内收眼的比值,参数包括峰速度、峰加速度、峰速度/幅度和扫视轨迹AUC。

临床怎么用

  • 红外眼动记录可作为MS中INO的客观量化诊断工具,有助于识别复视风险和生活质量受损的患者。

局限性

  • 基于红外眼动记录的INO标准需要前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We present an objective and quantitative approach for diagnosing internuclear ophthalmoplegia (INO) in multiple sclerosis (MS). METHODS: A validated standardized infrared oculography protocol (DEMoNS [Demonstrate Eye Movement Networks with Saccades]) was used for quantifying prosaccades in patients with MS and healthy controls (HCs). The versional dysconjugacy index (VDI) was calculated, which describes the ratio between the abducting and adducting eye. The VDI was determined for peak velocity, peak acceleration, peak velocity divided by amplitude, and area under the curve (AUC) of the saccadic trajectory. We calculated the diagnostic accuracy for the several VDI parameters by a receiver operating characteristic analysis comparing HCs and patients with MS. The National Eye Institute Visual Function Questionnaire-25 was used to investigate vision-related quality of life of MS patients with INO. RESULTS: Two hundred ten patients with MS and 58 HCs were included. The highest diagnostic accuracy was achieved by the VDI AUC of 15° horizontal prosaccades. Based on a combined VDI AUC and peak velocity divided by amplitude detection, the prevalence of an INO in MS calculated to 34%. In the INO group, 35.2% of the patients with MS reported any complaints of double vision, compared to 18.4% in the non-INO group (p = 0.010). MS patients with an INO had a lower overall vision-related quality of life (median 89.9, interquartile range 12.8) compared to patients without an INO (median 91.8, interquartile range 9.3, p = 0.011). CONCLUSIONS: This study provides an accurate quantitative and clinically relevant definition of an INO in MS. This infrared oculography-based INO standard will require prospective validation. The high prevalence of INO in MS provides an anatomically well described and accurately quantifiable model for treatment trials in MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Nij Bijvank JA, van Rijn LJ, Balk LJ, et al. Diagnosing and quantifying a common deficit in multiple sclerosis: Internuclear ophthalmoplegia. Neurology. 2019. PMID: 31004067. doi:10.1212/WNL.0000000000007499

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。